Comment on "Shadows Behind Using Simple Risk Models in Selection of Hepatocellular Carcinoma Patients for Liver Transplantation"
Ann Surg
.
2021 Dec 1;274(6):e832-e833.
doi: 10.1097/SLA.0000000000004511.
Authors
Federico Piñero
1
,
Fernando Rubinstein
2
,
Alexis Laurent
3
,
Marcelo Silva
1
,
Daniel Cherqui
4
,
Christophe Duvoux
5
Affiliations
1
Liver Transplant and Hepatology Unit, Hospital Universitario Austral, School of Biomedical Science, Austral University, Pilar, Argentina.
2
Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
3
Department of Liver Surgery, Henri-Mondor Hospital, APHP, Paris-Est University, Créteil, France.
4
Hepato-Biliary Center, Paul Brousse Hospital, Paris, France.
5
Department of Hepatology, Medical Liver Transplant Unit, Henri-Mondor Hospital, APHP, Paris-Est University, Créteil, France.
PMID:
33214429
DOI:
10.1097/SLA.0000000000004511
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Hepatocellular* / surgery
Humans
Liver Neoplasms* / surgery
Liver Transplantation*
Neoplasm Recurrence, Local
Patient Selection